5-Hydroxymethylation alterations in cell-free DNA reflect molecular distinctions of diffuse large B cell lymphoma at different primary sites

被引:0
|
作者
Ye Shen
Jinping Ou
Bo He
Jinmin Yang
Huihui Liu
Lihong Wang
Bingjie Wang
Liang Gao
Chengqi Yi
Jinying Peng
Xinan Cen
机构
[1] Peking University First Hospital,Department of Hematology
[2] Peking University,Peking
[3] Peking University,Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies
来源
Clinical Epigenetics | 2022年 / 14卷
关键词
Diffuse large B cell lymphoma; Primary sites; 5-hydroxymethylcytosine; Prognosis; Epigenetic biomarkers;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
    Lasse Sommer Kristensen
    Jakob Werner Hansen
    Søren Sommer Kristensen
    Dorte Tholstrup
    Laurine Bente Schram Harsløf
    Ole Birger Pedersen
    Peter De Nully Brown
    Kirsten Grønbæk
    Clinical Epigenetics, 2016, 8
  • [22] Targetable alterations in primary extranodal diffuse large B-cell lymphoma
    Weissinger, Stephanie E.
    Dugge, Rucha
    Disch, Miriam
    Barth, Thomas F.
    Bloehdorn, Johannes
    Zahn, Malena
    Marienfeld, Ralf
    Viardot, Andreas
    Moeller, Peter
    EJHAEM, 2022, 3 (03): : 688 - 697
  • [23] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [24] Serum cell-free DNA concentration as a possible prognostic marker in newly diagnosed diffuse large B-cell lymphoma
    Shirouchi, Yuko
    Mishima, Yuko
    Takayama, Tomoko
    Minowa, Sayuri
    Ishihara, Yuko
    Tamba, Mikako
    Hirano, Mitsuhito
    Onda, Naoki
    Takeuchi, Kengo
    Maruyama, Dai
    BIOMEDICAL RESEARCH-TOKYO, 2022, 43 (04): : 99 - 106
  • [25] A Novel Approach: Nanopore Sequencing of Native Cell-Free DNA in Diffuse-Large B-Cell Lymphoma Patients
    Erblich, Thomas
    Sauer, Carolin
    Muyas, Francesc
    Ficz, Gabriella
    Cortes-Ciriano, Isidro
    Gribben, John G.
    BLOOD, 2023, 142
  • [26] Identifying patterns of cell-free DNA associated with elevated risk of diffuse large B-cell lymphoma in adult dogs
    Burt, Lauren E.
    Treeful, Amy E.
    Lewellen, Mitzi
    Demos-Davies, Kimberly
    Chehadeh, Andrea
    Pracht, Sara
    Schulte, Ashley J.
    Feiock, Caitlin
    Medland, Julia
    Seelig, Davis
    Makielski, Kelly M.
    Khammanivong, Ali
    Borgatti, Antonella
    Henson, Michael S.
    Linden, Michael
    Vallera, Daniel
    Cutter, Gary R.
    Sarver, Aaron L.
    Modiano, Jaime F.
    CLINICAL CANCER RESEARCH, 2024, 30 (21)
  • [27] Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma
    Palanisamy, N
    Abou-Elella, AA
    Chaganti, SR
    Houldsworth, J
    Offit, K
    Louie, DC
    Terayu-Feldstein, J
    Cigudosa, JC
    Rao, PH
    Sanger, WG
    Weisenburger, DD
    Chaganti, RSK
    GENES CHROMOSOMES & CANCER, 2002, 33 (02): : 114 - 122
  • [28] Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
    Roschewski, Mark
    Phelan, James D.
    Wilson, Wyndham H.
    CANCER JOURNAL, 2020, 26 (03): : 195 - 205
  • [29] Genome-wide 5-hydroxymethylation mapping in cell-free DNA to characterize the epigenetic differences in minimal residual disease of multiple myeloma
    Zhang, Zhou
    Wang, Bei
    Kowitwanich, Krissana
    Cursio, John
    Appelbaum, Daniel
    He, Chuan
    Zhang, Wei
    Derman, Benjamin
    Chiu, Brian
    Jakubowiak, Andrzej
    CLINICAL CANCER RESEARCH, 2024, 30 (21)
  • [30] Primary breast diffuse large B cell lymphoma
    Guo, Mengni
    Liu, Jieying
    Gilmore, Richard
    Tian, Gang Gary
    BMJ CASE REPORTS, 2022, 15 (06)